G.Enrico Rovati
G.Enrico Rovati
Email verificata su unimi.it
TitoloCitata daAnno
The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo
N Chiang, CN Serhan, SE DahlÚn, JM Drazen, DWP Hay, GE Rovati, ...
Pharmacological reviews 58 (3), 463-487, 2006
4472006
The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl‐leukotrienes receptor
P Ciana, M Fumagalli, ML Trincavelli, C Verderio, P Rosa, D Lecca, ...
The EMBO journal 25 (19), 4615-4627, 2006
3742006
The highly conserved DRY motif of class AG protein-coupled receptors: beyond the ground state
GE Rovati, V Capra, RR Neubig
Molecular pharmacology 71 (4), 959-964, 2007
3282007
Cysteinyl‐leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends
V Capra, MD Thompson, A Sala, DE Cole, G Folco, GE Rovati
Medicinal research reviews 27 (4), 469-527, 2007
1732007
Leukotrienes as mediators of asthma
S Nicosia, V Capra, GE Rovati
Pulmonary pharmacology & therapeutics 14 (1), 3-19, 2001
1602001
Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7
M Bńck, WS Powell, SE DahlÚn, JM Drazen, JF Evans, CN Serhan, ...
British journal of pharmacology 171 (15), 3551-3574, 2014
1212014
International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions
M Bńck, SE DahlÚn, JM Drazen, JF Evans, CN Serhan, T Shimizu, ...
Pharmacological reviews 63 (3), 539-584, 2011
1132011
Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke
V Capra, M Bńck, SS Barbieri, M Camera, E Tremoli, GE Rovati
Medicinal research reviews 33 (2), 364-438, 2013
752013
Lower efficacy: interaction with an inhibitory receptor or partial agonism?
GE Rovati, S Nicosia
Trends in pharmacological sciences 15 (5), 140-144, 1994
741994
CysLT 1 receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1/2 phosphorylation
S Ravasi, S Citro, B Viviani, V Capra, GE Rovati
Respiratory research 7 (1), 42, 2006
732006
Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities
V Capra, M Ambrosio, G Riccioni, GE Rovati
Current medicinal chemistry 13 (26), 3213-3226, 2006
732006
CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors
L Mamedova, V Capra, MR Accomazzo, ZG Gao, S Ferrario, M Fumagalli, ...
Biochemical pharmacology 71 (1-2), 115-125, 2005
712005
CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: a possible feedback mechanism in inflammation
V Capra, S Ravasi, MR Accomazzo, S Citro, M Grimoldi, MP Abbracchio, ...
Journal of Cell Science 118 (23), 5625-5636, 2005
712005
Cysteinyl-leukotriene receptors and cellular signals
GE Rovati, V Capra
The Scientific World Journal 7, 1375-1392, 2007
682007
Mutational analysis of the highly conserved ERY motif of the thromboxane A2 receptor: alternative role in G protein-coupled receptor signaling
V Capra, A Veltri, C Foglia, L Crimaldi, A Habib, M Parenti, GE Rovati
Molecular pharmacology 66 (4), 880-889, 2004
682004
Prolonged in vitro exposure of rat brain slices to adenosine analogues: selective desensitization of adenosine A1 but not A2 receptors
MP Abbracchio, G Fogliatto, AM Paoletti, GE Rovati, F Cattabeni
European Journal of Pharmacology: Molecular Pharmacology 227 (3), 317-324, 1992
621992
4‐Oxystilbene compounds are selective ligands for neuronal nicotinic αBungarotoxin receptors
C Gotti, B Balestra, M Moretti, GE Rovati, L Maggi, G Rossoni, F Berti, ...
British journal of pharmacology 124 (6), 1197-1206, 1998
601998
Transcellular biosynthesis of eicosanoid lipid mediators
V Capra, GE Rovati, P Mangano, C Buccellati, RC Murphy, A Sala
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipidsá…, 2015
582015
Pranlukast: a review of its use in the management of asthma
SJ Keam, KA Lyseng-Williamson, KL Goa
Drugs 63 (10), 991-1019, 2003
562003
International Union of Pharmacology XLIV. Nomenclature for the oxoeicosanoid receptor
C Brink, SE Dahlen, J Drazen, JF Evans, DWP Hay, GE Rovati, ...
Pharmacological reviews 56 (1), 149-157, 2004
532004
Il sistema al momento non pu˛ eseguire l'operazione. Riprova pi¨ tardi.
Articoli 1–20